The FDA has accepted Toralgen’s polybile nanopill into its Emerging Technology Program. Getting into the program sets Toralgen up to meet with the FDA’s emerging technology team to resolve potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results